Verisante Technology Inc.

Verisante Technology Inc. is committed to helping save lives through the commercialization of innovative systems for the detection of cancer. The company's initial focus is skin cancer, including basal cell carcinoma, squamous cell carcinoma and melanoma. Verisante has licensed a technology developed by the BC Cancer Agency for in vivo, real-time, noninvasive skin measurements. This platform technology may also be applied to detection systems for other types of cancer including lung, gastrointestinal, colorectal and cervical cancers.